Kibur Medical Inc’s Post

Join our Syneos Health Consulting team at JPM's Biotech Showcase next week in this panel discussion to learn more about how to invest for success in today's challenging environment!

🎥 Dive into the Future of Regenerative Medicines with David Sourdive, EVP CMC & Manufacturing at Cellectis! 🌐 https://ow.ly/4IT050Qcn28 🔗 In this exclusive interview, David Sourdive explores the potential and challenges of allogeneic therapies, shedding light on their role in revolutionizing regenerative medicines. 🚀 Discover the advantages of donor-derived therapies and gain insights into the manufacturing processes that are driving innovation in the field. 👉 Click the above link to watch the interview 🔗 #AllogeneicTherapies #CellandGeneTherapy #AdvancedTherapiesEurope #RegenerativeMedicine

Our business model takes a page from the #Biotech playbook by leveraging risk-reward sharing partnerships to bring clinically impactful treatments to patients. Check out CEO David Hochman's #LSIUSA24 presentation, which summarizes our unique approach to #MedTech innovation: https://bit.ly/4dphr6Y LSI #Hypertension #AtheroscleroticArteryDisease

We understand the viral-vector manufacturing challenges our health innovators face: bottlenecks, lack of expertise, and high costs. Let’s discuss how we can help alleviate these roadblocks and provide expertise to accelerate your viral-vector manufacturing pathway from preclinical to clinical and commercial production. [email protected]   #biotech #genetherapy #biotechnology #gmp  #cellandgenetherapy #healthcare  #healthtech

Want to stay ahead in the biotech industry? Subscribe to Fierce Biotech Newsletters for the latest breakthroughs and industry updates straight to your inbox. Industry professionals and leaders rely on the awards winning Fierce Biotech to make informed decisions and lead impactful conversations. Don't miss out on staying informed and ahead of the curve. What biotech trend are you following this year? Follow Fierce Biotech 🔗https://hubs.ly/Q02HZQ9R0 #FierceBiotech #BiotechNews #IndustryUpdates #StayInformed

At the #BioFIT2023 conference today, speaking about the key drivers for #collaboration between pharma and academia on “Best practices in managing early-stage academia-industry collaborations” #publicprivate #animalhealth #research #europe

Early Bird rates for Bio€quity Europe ends Friday - register now to save! With 60+ biotechs already confirmed to present, this year’s event in San Sebastián is expected to sell out, again. In fact, we are on track to exceed last year, when 300 VCs, 330 CEOs, and 150 C-level executives joined. This year we will gather in Basque Country to discuss how biotechs can rise above the noise to attract the right investors, partners, and talent. I hope you will join BioCentury Inc., EBD Group, and Regional Host Committee Chair Ysios Capital in one of the culinary capitals of the world. Register for #BioEquityEurope by Friday to save: https://ow.ly/lkOl50QyYeS Learn more, including the schedule-at-a-glance and presenting companies you will meet: https://ow.ly/8B5c50QyYeR #biotech #biopharma

🔍 Explore Mr. Kamal's journey, spanning over three decades, as he shares insights on navigating challenges, prioritizing compliance, and steering through the complex world of finance in the pharma industry. With leaders like Zulfiquar Kamal driving us forward, we at ZIM Labs, are optimistic about the incredible innovations and breakthroughs awaiting us. 🌐 To Know More : https://lnkd.in/dwzkBFDE #ZIMLabs #Tradeflock #PharmaInnovation #GlobalImpact #HealthTech #MedTech #ResearchAndDevelopment #MedicalAdvancements #PharmaIndustry #Biotechnology #HealthScience #SustainableHealth #MedicalInnovations #HealthcareSolutions #PharmaceuticalResearch #ClinicalTrials #MedicineDevelopment #HealthcareLeaders #GlobalHealth #HealthcarePartnerships #PharmaInnovators

Get to know PRISM Biotech Index’s Newest Addition: hims & hers Health, Inc. (NYSE: $HIMS)  https://bit.ly/3HPMSc6 #stockstowatch #stocksinnews #investors #smallcaps #biotech #HimAndHersHealth #PrismMediaWire #PrismMarketView #PrismDigitalMedia

🔬✨ We spoke with Joris Pezzini, Executive Vice President of Biopharma at Alira Health, to gain insights into biotech trends and industry insights for 2024 and beyond. Read the full interview with Pezzini to learn more about the challenges and triumphs faced by biotech companies today: https://buff.ly/3SJn1ZV #Biotech #BiotechAcquisition #Biotechnology